Year Established :
2005
Total Assets(USD) :
Less than 500,000
Total Number of Staff :
Less than 10 persons
Other Competitive Advantages :
Most of our products comply with such pharmacopoeia standards as USP, EP, JP, CP, with GMP certificate and DMF(in CTD).
Business Type :
,Manufacturer
Annual Turnover(USD) :
7,000,000 to 7,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Fine Chemicals
Product Range :
Glipizide; Flunarizine dihydrochloride; Loxoprofen sodium; 4-(2-Aminoethyl)benzene sulfonamide; etc